Clinical Trials
775
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (329 trials with phase data)• Click on a phase to view related trials
Anderson Fabry Disease - the Power of Information.
- Conditions
- Fabry Disease
- First Posted Date
- 2025-08-22
- Last Posted Date
- 2025-08-22
- Target Recruit Count
- 20
- Registration Number
- NCT07136662
- Locations
- 🇮🇹
Fondazione Policlinico Gemelli IRCCS, Roma, RM, Italy
Health Oriented Protocol for Epidermal Radiodermatitis
- Conditions
- Head and Neck CancerGynecologic CancerPelvic CancerRadiation Skin InjuryRadiotherapy Side Effect
- First Posted Date
- 2025-08-19
- Last Posted Date
- 2025-08-19
- Target Recruit Count
- 80
- Registration Number
- NCT07129525
2D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices
- Conditions
- Portal Hypertension Related to CirrhosisEsophageal Varices
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Target Recruit Count
- 450
- Registration Number
- NCT07122622
Aortic Dissection fAlse enlarGement radIomics predictiOn
- Conditions
- DissectionAortic DiseasesAortic Dissection
- First Posted Date
- 2025-08-12
- Last Posted Date
- 2025-08-12
- Target Recruit Count
- 500
- Registration Number
- NCT07117825
- Locations
- 🇮🇹
Giovanni Tinelli, Roma, Italy
O2 Consumption And CO2 Production After Hemodynamic Optimization In Shock
- Conditions
- Hemodynamic InstabilityOxygen Consumption (V̇O2)
- First Posted Date
- 2025-08-06
- Last Posted Date
- 2025-08-06
- Target Recruit Count
- 36
- Registration Number
- NCT07107724
- Locations
- 🇮🇹
Policlinico Universitario Fondazione Agostino Gemelli IRCCS, Roma, Italy
- Prev
- 1
- 2
- 3
- 4
- 5
- 152
- Next
News
EndoZip™ Automated Endoscopic System Shows 11.4% Weight Loss and Improved Comorbidities in Obesity Trial
Interim clinical data from the EndoZip™ automated endoscopic suturing system demonstrated an average total body weight loss of 11.4% at twelve months in patients with class I and II obesity.
Secure Multiparty Computation Enables Privacy-Friendly Evaluation of Patient Data in Adrenal Gland Metastasis Study
A bicenter, prospective, longitudinal observational study utilized MR-guided radiotherapy (MRgRT) to treat adrenal gland metastasis, emphasizing precision and minimizing radiation exposure.